Approved for LOARGYS is indicated for the treatment of hyperargininemia in adult and pediatric patients 2 years of age and older with Arginase 1 Deficiency (ARG1-D), in conjunction with dietary protein restriction. This indication is approved under accelerated approval based on reduction of plasma arginine.. LOARGYS provides an exogenous source of the deficient human arginase 1 enzyme activity…
Loading full data from Know Your Drugs Institute…